Skip to main content

Cordyceps Sunshine Biotech Holdings Co., Ltd.

corporate_fare Company Profile

Cordyceps Sunshine Biotech Holdings Co., Ltd.

RAJAF·OTC·Life Sciences·CIK 0001885680

Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in cultivating and selling Cattle camphor mushroom. The company, incorporated on May 4, 2020, under the laws of the Cayman Islands, initially established a wholly owned subsidiary, Cordyceps Sunshine Biotech Co., Ltd ("Cordyceps Sunshine HK"), in Hong Kong on June 5, 2020. On the same day, Cordyceps Sunshine HK established Chengdu Skyherb Biotechnology Co., Ltd ("Chengdu Skyherb") as a wholly owned subsidiary in the People's Republic of China. On November 3, 2021, Cordyceps Sunshine Cayman also established a branch, Cordyceps Sunshine Taiwan Branch, in Taiwan, Republic of China. On September 28, 2023, the company entered into an agreement to sell 100% equity interest in Cordyceps Sunshine HK to Mr. Xusheng Niu. In exchange, Mr. Niu agreed to cancel a debt totaling $1,152,328.50 (RMB8,411,156.95) owed by the company, which originated from loan agreements since June 29, 2020. This transaction resulted in the company spinning off its subsidiaries, Cordyceps Sunshine HK and Chengdu Skyherb. Taiwanofungus Biotech Co. Ltd., incorporated on August 17, 2023, in Hong Kong, is currently not actively engaged in any business.

Cordyceps Sunshine Biotech Holdings Co., Ltd. (OTC:RAJAF) is a publicly traded company in the Life Sciences sector. Wiseek monitors RAJAF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cordyceps Sunshine Secures Exclusive Global Commercialization Rights for Antcin A Drug Platform
  • Going Concern Warning, Material Weakness in Controls, and Recurring Losses Highlight Financial Distress

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.25M
Net Income
-$154.82K
Diluted EPS
$0.00
Op. Cash Flow
-$35.84K
Gross Profit
$760.74K
Operating Income
-$141.13K
Cash & Equivalents
$3.2K
Debt / Equity
0.00×
Net Margin
-12.4%
Shares Outstanding
111.12M sh
Source: 20-F · filed 2026-05-15 · accession 0001213900-26-057774

Insider Transactions

RAJAF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with R →
$5.2
52-week range · as of 2026-06-25 $0.04 – $10.56
Market cap
$577.82M
Volume
261 (0.3× avg)
3-mo avg 1K
Live data · 2026-06-30 00:37 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed RAJAF - Latest Insights

RAJAF
Jun 25, 2026, 6:08 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.20
Real-time Price: $5.20 info
Change: $0 (0%) info
Market Cap: $577.824M info
RAJAF
May 15, 2026, 4:16 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $5.20
Real-time Price: $5.20 info
Change: $0 (0%) info
Market Cap: $577.824M info